BioVie Inc.
BIVI
$1.03
-$0.06-5.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -37.33% | 21.99% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -59.03% | 76.92% | |||
| Operating Income | 59.03% | -76.92% | |||
| Income Before Tax | 60.80% | -71.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 60.80% | -71.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 60.80% | -71.30% | |||
| EBIT | 59.03% | -76.92% | |||
| EBITDA | 59.49% | -78.01% | |||
| EPS Basic | 66.91% | 34.91% | |||
| Normalized Basic EPS | 66.69% | 30.28% | |||
| EPS Diluted | 67.24% | 34.29% | |||
| Normalized Diluted EPS | 66.69% | 30.28% | |||
| Average Basic Shares Outstanding | 17.75% | 145.64% | |||
| Average Diluted Shares Outstanding | 17.75% | 145.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||